Haematologica 2015 Jan;100(1):e39
Radotinib in the treatment of chronic phase chronic myeloid leukemia patients.
Eskazan AE1, Soysal T2.
chronic myeloid leukemia; imatinib; radotinib; tyrosine kinase inhibitor
ukemia; imatinib; radotinib; tyrosine kinase inhibitor